Article
Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.
BMC infectious diseases - 28 Jun 2009
Murray Ruth, Boyd Dave, Levett Paul N, Mulvey Michael R, Alfa Michelle J
Abstract excerpt
BACKGROUND: The increased severity of disease associated with the NAP1 strain of Clostridium difficile has been attributed to mutations to the tcdC gene which codes for a negative regulator of toxin production. To assess the role of hyper-production of Toxins A and B in clinical isolates of Clostridium difficile, two NAP1-related and five NAP1 non-related strains were compared. METHODS: Sequencing was performed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
